Screener
10x Genomics, Inc. TXG Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue | 23,610 | 23,902 |
| Operating lease liabilities | 12,015 | 10,985 |
| Contingent consideration, current | 7,069 | 23,363 |
| Total current liabilities | 118,509 | 153,454 |
| Contingent consideration, noncurrent | 2,991 | 1,237 |
| Operating lease liabilities, noncurrent | 66,781 | 73,376 |
| Deferred revenue, noncurrent | 9,683 | 10,501 |
| Other noncurrent liabilities | 6,556 | 6,471 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s total current liabilities?
- 10x Genomics, Inc. (TXG) reported total current liabilities of $118.51M in Q2 2026.
- How has 10x Genomics, Inc.'s total current liabilities changed year-over-year?
- 10x Genomics, Inc.'s total current liabilities increased by 5.6% year-over-year, from $112.22M to $118.51M.
- What is the long-term trend for 10x Genomics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total current liabilities has grown at a 5.4% compound annual growth rate (CAGR), from $118.13M to $153.45M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about 10x Genomics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude